Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
PHASE1
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3
PHASE4
In countries with a high tuberculosis (TB) prevalence, TB and invasive bact...
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants
PHASE2
The study will begin with a two-week lead-in period (W-2 and W-1), when par...